Bretigny sur Orge, France

Eric Valeur

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Bretigny sur Orge, FR (2012 - 2016)
  • Vieux-Ferrette, FR (2013 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **The Innovations of Eric Valeur: A Pioneer in Diabetes Treatment**

Introduction

Eric Valeur, an accomplished inventor based in Bretigny sur Orge, France, has made significant contributions to the field of diabetes treatment through his innovative patent portfolio. With a total of eight patents to his name, Valeur has focused much of his work on methods to stimulate insulin secretion and address the challenges posed by hyperglycemia. His groundbreaking inventions have the potential to provide new avenues for the treatment and prophylaxis of diabetes and associated pathologies.

Latest Patents

Among his latest patents, Eric Valeur has developed a method for stimulating insulin secretion and modulating INS-1 kinase using substituted pyrazinones and tetrahydroquinoxalinones. Specifically, his patented arylpyrazinone derivatives serve as insulin secretion stimulators, and the preparation and application of these compounds have implications for diabetes management. Additionally, he has introduced quinoxalinone derivatives that also act as insulin secretion stimulators, detailing methods for their preparation and use in treating diabetes. This current research emphasizes the importance of these compounds in modulating insulin secretion in insulin-1 cells, demonstrating their therapeutic potential.

Career Highlights

Throughout his career, Eric Valeur has been associated with notable pharmaceutical companies, including Merck Patent GmbH and Merck Patent Gesellschaft mit Beschränkter Haftung. His experience in these organizations has strengthened his expertise in the development of innovative pharmaceutical solutions, specifically targeting metabolic disorders.

Collaborations

Eric has collaborated with talented individuals in the field, notably Micheline R. Kergoat and Christine G. Charon. Working alongside such distinguished colleagues has fostered an environment of creativity and innovation, further enhancing the quality and applicability of his inventions.

Conclusion

As a dedicated inventor, Eric Valeur's contributions to the field of diabetes treatment stand as a testament to his innovative spirit. With a focus on developing compounds that effectively stimulate insulin secretion, his work continues to pave the way for advancements in medical treatments, offering hope for those affected by diabetes. Through his patents, collaborations, and unwavering commitment, Valeur has established himself as an influential figure in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…